Matrix metalloproteinase-3 differences in oral and skin fibroblasts

Journal of Dental Research

Volumn 86, Issue 5, 2007, Pages 457-462

  McKeown, S T W ^a   Barnes, J J ^a   Hyland, P L ^a   Lundy, F T ^a   Fray, M J ^b   Irwin, C R ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Fibroblasts; MMP3; TGF ; Wound contraction; Wound healing

Indexed keywords

ACTIN; COLLAGEN TYPE 1; ISOPROTEIN; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; FIBROBLAST; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; HUMAN; MOUTH MUCOSA; PHYSIOLOGY; SKIN; WOUND HEALING;

ACTINS; ADULT; CELLS, CULTURED; COLLAGEN TYPE I; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASE 3; MOUTH MUCOSA; PROTEIN ISOFORMS; SKIN; SKIN PHYSIOLOGY; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 34249303748     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910708600513     Document Type: Article

References (25)

1. Bullard KM, Lund L, Mudgett JS, Mellin TN, Hunt TK, Murphy B, et al. (1999a). Impaired wound contraction in stromelysin-1deficient mice. Ann Surg 230:260-265.
2. Bullard KM, Mudgett J, Scheuenstuhl H, Hunt TK, Banda MJ (1999b). Stromelysin-1-deficient fibroblasts display impaired contraction in vitro. J Surg Res 84:31-34.
3. Daniels JT, Cambrey AD, Occleston NL, Garrett Q, Tarnuzzer RW, Schultz GS, et al. (2003). Matrix metalloproteinase inhibition modulates fïbroblast-mediated matrix contraction and collagen production in vitro. Invest Ophthalmol Vis Sci 44:1104-1110.
4. Ehrlich HP, Rajaratnam JB (1990). Cell locomotion forces versus cell contraction forces for collagen lattice contraction: an in vitro model of wound contraction. Tissue Cell 22:407-417.
5. Gould LJ, Yager DR, Cohen IK (1997). In vitro analysis of fetal fibroblast collagenolytic activity. Wound Repair Reg 5:151-158.
6. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y (1997). Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor beta-1 release. Biochem J 322(Pt 3):809-814.
7. Irwin CR, Picardo M, Ellis I, Sloan P, Grey AM, McGurk M, et al. (1994). Inter- and intra-site heterogeneity in the expression of fetal-like characteristics by gingival fibroblasts: potential significance for wound healing. J Cell Sei 107(Pt 5):1333-1346.
8. Irwin CR, Myrillas T, Smyth M, Doogan J, Rice C, Schor SL (1998). Regulation of fibroblast-induced collagen gel contraction by interleukin- Ibeta. J Oral Pathol Med 27:255-259.
9. Knerer B, Formanek M, Temmel A, Martinek H, Schickinger B, Kornfehl J (1999). The role of fibroblasts from oropharyngeal mucosa in producing proinflammatory and mitogenic cytokines without prior stimulation. Eur Arch Otorhinolaryngol 256:266-270.
10. Kohama K, Nonaka K, Hosokawa R, Shum L, Ohishi M (2002). TGFbeta-3 promotes scarless repair of cleft lip in mouse fetuses. J Dent Res 81:688-694.
11. Krummel TM, Michna BA, Thomas BL, Sporn MB, Nelson JM, Salzberg AM, et al. (1988). Transforming growth factor-beta (TGF-beta) induces fibrosis in a wound healing model. J Paediatr Surg 23:647-652.
12. Lanning DA, Diegelmann RF, Yager DR, Wallace ML, Bagwell CE, Haynes JH (2000). Myofibroblast induction with transforming growth factor-beta 1 and -beta3 in cutaneous fetal excisional wounds. J Paediatr Surg 35:183-188.
13. McKeown ST, Hyland PL, Locke M, Mackenzie 1C, Irwin CR (2003). Keratinocyte growth factor and scatter factor expression by regionally defined oral fibroblasts. Eur J Oral Sci 111:42-50.
14. Mirastschijski U, Haaksma CJ, Tomasek JJ, Agren MS (2004). Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Exp Cell Res 299:465-475.
15. Morishima Y, Nomura A, Uchida Y, Noguchi Y, Sakamoto T, Ishii Y, et al. (2001). Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am J Respir Cell Mol Biol 24:l-11.
16. Rittie L, Berton A, Monboisse JC, Hornebeck W, Gillery P (1999). Decreased contraction of glycated collagen lattices coincides with impaired matrix metalloproteinase production. Biochem Biophys Res Commun 264:488-492.
17. Schor SL (1980). Cell proliferation and migration on collagen substrata in vitro. J Cell Sci 41:159-175.
18. Scott KA, Wood EJ, Karran EH (1998). A matrix metalloproteinase inhibitor which prevents fibroblast-mediated collagen lattice contraction. FEES Lett 441:137-140.
19. Shah M, Foreman DM, Ferguson MW (1995). Neutralisation of TGFbetal and TGF-beta2 or exogenous addition of TGF-beta3 to cutaneous rat wounds reduces scarring. J Cell Sci 108(Pt 3):985-1002.
20. Shannon DB, McKeown STW, Lundy FT, Irwin CR (2006). Phenotypic differences between oral and skin fibroblasts in wound contraction and growth factor expression. Wound Rep Regen 14:172-178.
21. Stephens P, Davies KJ, Al-Khateeb T, Shepherd JP, Thomas DW (1996). A comparison of the ability of intra-oral and extra-oral fibroblasts to stimulate extracellular matrix reorganization in a model of wound contraction. J Dent Res 75:1358-1364.
22. Stephens P, Davies KJ, Occleston N, Pleass RD, Kon C, Daniels J, et al. (2001). Skin and oral fibroblasts exhibit phenotypic differences in extracellular matrix reorganisation and matrix metalloproteinase activity. Br J Dermatol 144:229-237.
23. Szpaderska AM, Zuckerman JD, DiPietro LA (2003). Differential injury responses in the oral mucosal and cutaneous wounds. J Dent Res 82:621-626.
24. Vaughan MB, Howard EW, Tomasek JJ (2000). Transforming growth factor-betal promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 257:180-189.
25. Whitby DJ, Ferguson MW (1991). The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development 112:651-668.